BARCLAYS PLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 3 filers reported holding BEAM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,752
+2.9%
197,647
+36.7%
0.00%0.0%
Q2 2023$4,617
+30.4%
144,532
+25.0%
0.00%
+50.0%
Q1 2023$3,542
-25.5%
115,629
-4.9%
0.00%0.0%
Q4 2022$4,757
-99.9%
121,619
+11.8%
0.00%
-66.7%
Q3 2022$5,179,000
+339.3%
108,736
+256.9%
0.01%
+500.0%
Q2 2022$1,179,000
+37.3%
30,469
+102.8%
0.00%0.0%
Q1 2022$859,00015,0250.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
HSG Holding Ltd 1,127,934$31,582,0005.60%
Omega Fund Management, LLC 302,821$8,479,0002.32%
Redmile Group, LLC 3,356,958$93,995,0001.74%
BRANDYWINE MANAGERS, LLC 10,875$305,0001.25%
DC Investments Management, LLC 88,100$2,467,0000.91%
Alphabet Inc. 663,691$18,583,0000.86%
Cormorant Asset Management, LP 796,429$22,036,0000.84%
HHLR ADVISORS, LTD. 2,966,403$83,059,0000.76%
Temasek Holdings (Private) Ltd 3,354,641$93,930,0000.56%
Granahan Investment Management 96,598$2,705,0000.10%
View complete list of BEAM THERAPEUTICS INC shareholders